Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.84M Buy
27,962
+2,815
+11% +$1M 0.14% 101
2025
Q4
$8.23M Buy
25,147
+3,271
+15% +$1.04M 0.12% 114
2025
Q3
$6.17M Buy
21,876
+8,341
+62% +$2.42M 0.11% 124
2025
Q2
$3.78M Buy
13,535
+12,122
+858% +$3.43M 0.08% 124
2025
Q1
$440K Buy
+1,413
New +$417K 0.01% 269
2024
Q3
Sell
-1,645
Closed -$514K 283
2024
Q2
$514K Sell
1,645
-508
-24% -$149K 0.02% 240
2024
Q1
$612K Buy
+2,153
New +$630K 0.02% 239
2023
Q2
Sell
-8,469
Closed -$2.05M 330
2023
Q1
$2.05M Sell
8,469
-1,261
-13% -$310K 0.11% 85
2022
Q4
$2.56M Buy
9,730
+5,343
+122% +$1.43M 0.16% 61
2022
Q3
$989K Sell
4,387
-2,704
-38% -$655K 0.06% 125
2022
Q2
$1.73M Buy
7,091
+4,153
+141% +$1.02M 0.09% 89
2022
Q1
$710K Buy
2,938
+845
+40% +$194K 0.03% 199
2021
Q4
$471K Buy
2,093
+332
+19% +$70.1K 0.02% 186
2021
Q3
$374K Sell
1,761
-4
-0.2% -$921 0.02% 199
2021
Q2
$435K Sell
1,765
-669
-27% -$165K 0.03% 151
2021
Q1
$606K Buy
2,434
+806
+50% +$192K 0.09% 111
2020
Q4
$386K Buy
+1,628
New +$375K 0.04% 140

Other funds holding AMGN

AIA Group's AMGN Position: Q1 2026 in Review

AIA Group increased its Amgen (AMGN) stake by 11% in Q1 2026, buying an estimated $1M and bringing the position to 27,962 shares worth $9.84M. The position accounts for 0.14% of the portfolio, ranked #101.

AIA Group first reported a position in AMGN in Q4 2020 and has held it in 17 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AIA Group held 27,962 shares of Amgen worth $9.84M as of Q1 2026.
  • AIA Group bought 2,815 Amgen shares in Q1 2026, an estimated $1M.
  • Amgen made up 0.14% of AIA Group's portfolio in Q1 2026, its #101 holding.
  • AIA Group first reported a position in Amgen in Q4 2020 and has held it in 17 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.